Mangalam Drugs & Organics Limited (NSE:MANGALAM)
80.38
+0.89 (1.12%)
Jun 2, 2025, 3:29 PM IST
Mangalam Drugs & Organics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 25.89 | 11.87 | 26.88 | 19.55 | 5.92 | Upgrade
|
Cash & Short-Term Investments | 25.89 | 11.87 | 26.88 | 19.55 | 5.92 | Upgrade
|
Cash Growth | 118.07% | -55.84% | 37.54% | 230.26% | -63.67% | Upgrade
|
Accounts Receivable | 390.73 | 279.44 | 465.33 | 464.9 | 543.12 | Upgrade
|
Receivables | 401.67 | 291.1 | 465.78 | 465.26 | 543.21 | Upgrade
|
Inventory | 1,388 | 1,236 | 1,375 | 1,171 | 585.88 | Upgrade
|
Prepaid Expenses | - | 16.1 | 18.74 | 20.54 | 18.97 | Upgrade
|
Other Current Assets | 174.26 | 204.53 | 179.77 | 173.92 | 185.24 | Upgrade
|
Total Current Assets | 1,990 | 1,760 | 2,066 | 1,850 | 1,339 | Upgrade
|
Property, Plant & Equipment | 1,336 | 1,269 | 1,336 | 1,268 | 1,142 | Upgrade
|
Long-Term Investments | 0.04 | 0.04 | 0.04 | 0.04 | 2.24 | Upgrade
|
Other Intangible Assets | 318.3 | 285.18 | 182.99 | 138.76 | 99.57 | Upgrade
|
Other Long-Term Assets | 20.08 | 22.91 | 11.89 | 27.18 | 57.94 | Upgrade
|
Total Assets | 3,664 | 3,337 | 3,596 | 3,284 | 2,641 | Upgrade
|
Accounts Payable | 911.49 | 661.62 | 970.73 | 545.47 | 433.95 | Upgrade
|
Accrued Expenses | 11.04 | 40.57 | 40.01 | 38.29 | 35.66 | Upgrade
|
Short-Term Debt | 719.37 | 745.96 | 495.67 | 470.96 | 511.82 | Upgrade
|
Current Portion of Long-Term Debt | 70.65 | 84.99 | 62.59 | 66.15 | 59.06 | Upgrade
|
Current Portion of Leases | 54.79 | 54.09 | 72.15 | 38.77 | 25.53 | Upgrade
|
Current Income Taxes Payable | 9.18 | - | 3.76 | 22.7 | - | Upgrade
|
Current Unearned Revenue | - | 46.61 | - | - | - | Upgrade
|
Other Current Liabilities | 139.48 | 6.78 | 8.67 | 118.81 | 24.77 | Upgrade
|
Total Current Liabilities | 1,916 | 1,641 | 1,654 | 1,301 | 1,091 | Upgrade
|
Long-Term Debt | 92.33 | 133.54 | 187.66 | 251.03 | 68.76 | Upgrade
|
Long-Term Leases | 25.16 | 51.34 | 67.39 | 52.14 | 31.9 | Upgrade
|
Long-Term Deferred Tax Liabilities | 98.15 | 120.86 | 145.16 | 134.95 | 141.79 | Upgrade
|
Other Long-Term Liabilities | 42.79 | 32.72 | 0 | 0.01 | 0.01 | Upgrade
|
Total Liabilities | 2,174 | 1,979 | 2,077 | 1,779 | 1,333 | Upgrade
|
Common Stock | 158.28 | 158.28 | 158.28 | 158.28 | 158.28 | Upgrade
|
Additional Paid-In Capital | - | 223.75 | 223.75 | 223.75 | 223.75 | Upgrade
|
Retained Earnings | - | 975.9 | 1,141 | 1,128 | 931.27 | Upgrade
|
Comprehensive Income & Other | 1,332 | - | -3.02 | -4.27 | -5.44 | Upgrade
|
Shareholders' Equity | 1,490 | 1,358 | 1,520 | 1,506 | 1,308 | Upgrade
|
Total Liabilities & Equity | 3,664 | 3,337 | 3,596 | 3,284 | 2,641 | Upgrade
|
Total Debt | 962.3 | 1,070 | 885.47 | 879.04 | 697.07 | Upgrade
|
Net Cash (Debt) | -936.41 | -1,058 | -858.58 | -859.5 | -691.15 | Upgrade
|
Net Cash Per Share | -59.22 | -66.85 | -54.24 | -54.30 | -43.67 | Upgrade
|
Filing Date Shares Outstanding | 14.85 | 15.83 | 15.83 | 15.83 | 15.83 | Upgrade
|
Total Common Shares Outstanding | 14.85 | 15.83 | 15.83 | 15.83 | 15.83 | Upgrade
|
Working Capital | 73.84 | 119.39 | 412.27 | 549.19 | 248.43 | Upgrade
|
Book Value Per Share | 100.32 | 85.79 | 96.00 | 95.12 | 82.63 | Upgrade
|
Tangible Book Value | 1,171 | 1,073 | 1,337 | 1,367 | 1,208 | Upgrade
|
Tangible Book Value Per Share | 78.89 | 67.77 | 84.44 | 86.36 | 76.34 | Upgrade
|
Land | - | 11.29 | 5.44 | 5.44 | 5.44 | Upgrade
|
Buildings | - | 371.23 | 370.13 | 369.83 | 333.89 | Upgrade
|
Machinery | - | 1,661 | 1,604 | 1,592 | 1,429 | Upgrade
|
Construction In Progress | - | - | 64.04 | 1.8 | 48.69 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.